First Time Loading...
C

Cabio Biotech Wuhan Co Ltd
SSE:688089

Watchlist Manager
Cabio Biotech Wuhan Co Ltd
SSE:688089
Watchlist
Price: 19.65 CNY 11.77% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Cabio Biotech Wuhan Co Ltd

Wall Street analysts forecast Cabio Biotech Wuhan Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Cabio Biotech Wuhan Co Ltd is 17.34 CNY with a low forecast of 17.17 CNY and a high forecast of 17.85 CNY.

Lowest Forecast
Wall Street Target
17.17 CNY
13% Downside
Average Forecast
Wall Street Target
17.34 CNY
12% Downside
Highest Forecast
Wall Street Target
17.85 CNY
9% Downside
Lowest
Price Target
17.17 CNY
13% Downside
Average
Price Target
17.34 CNY
12% Downside
Highest
Price Target
17.85 CNY
9% Downside
Cabio Biotech Wuhan Co Ltd Competitors:
Price Targets
HPOL B
Hexpol AB
10% Upside
4720
Tex Year Industries Inc
94% Upside
H
4112
Hodogaya Chemical Co Ltd
58% Upside
D
005290
Dongjin Semichem Co Ltd
31% Downside
HPOL B
Hexpol AB
10% Upside
4720
Tex Year Industries Inc
94% Upside
H
4112
Hodogaya Chemical Co Ltd
58% Upside
D
005290
Dongjin Semichem Co Ltd
31% Downside
BRG
Borregaard ASA
15% Upside
A
688733
Anhui Estone Materials Technology Co Ltd
30% Upside
FINEORG
Fine Organic Industries Ltd
2% Upside
000830
Luxi Chemical Group Co Ltd
21% Upside

Revenue
Forecast

Revenue Estimate
Cabio Biotech Wuhan Co Ltd

For the last 5 years the compound annual growth rate for Cabio Biotech Wuhan Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 18%.

14%
Past Growth
18%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Cabio Biotech Wuhan Co Ltd

For the last 5 years the compound annual growth rate for Cabio Biotech Wuhan Co Ltd's operating income is 5%.

5%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Cabio Biotech Wuhan Co Ltd

For the last 5 years the compound annual growth rate for Cabio Biotech Wuhan Co Ltd's net income is 0%. The projected CAGR for the next 3 years is 34%.

0%
Past Growth
34%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Cabio Biotech Wuhan Co Ltd's stock price target?
Price Target
17.34 CNY

According to Wall Street analysts, the average 1-year price target for Cabio Biotech Wuhan Co Ltd is 17.34 CNY with a low forecast of 17.17 CNY and a high forecast of 17.85 CNY.

What is Cabio Biotech Wuhan Co Ltd's Revenue forecast?
Projected CAGR
18%

For the last 5 years the compound annual growth rate for Cabio Biotech Wuhan Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 18%.

What is Cabio Biotech Wuhan Co Ltd's Net Income forecast?
Projected CAGR
34%

For the last 5 years the compound annual growth rate for Cabio Biotech Wuhan Co Ltd's net income is 0%. The projected CAGR for the next 3 years is 34%.

ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.